WashU Medicine Knight ADRC

10/16/2026

Diagnosed with Alzheimer’s at 46, Francisco Rios and his wife share their journey to diagnosis, the challenges of younger-onset dementia, and their hopes for an experimental treatment.

Diagnosed with Alzheimer’s at 46, Francisco Rios and his wife share the challenges of young-onset dementia, and their hopes for an experimental treatment.

10/15/2026

A rare examination of an Alzheimer’s patient’s brain revealed that regions cleared of amyloid plaques had remarkably little of the harmful tau buildup associated with memory loss, while neighboring areas showed extensive damage.

A rare examination of an Alzheimer’s patient’s brain revealed that regions cleared of amyloid plaques had remarkably little of the harmful tau buildup associated with memory loss, while neighboring areas showed extensive damage. The discovery suggests that removing amyloid may have lasting prote...

10/12/2026

I Couldn’t Cure My Dad’s Alzheimer’s. Here’s What I Could Heal.

Making a book of my dad’s train photos shifted my gaze away from all that he was losing.

10/12/2026

Biologist Keith Hengen’s research is getting deeper into sleep, unraveling the great mystery of slumber’s purpose in the brain and the body.

10/07/2026

Closing the gap in Alzheimer’s research - WashU Knight ADRC discussion examines disparities, trust and Black participation | The St. Louis American

Black Americans are roughly twice as likely as White Americans to have Alzheimer’s or another dementia, a disparity researchers are working to better understand while increasing participation from underrepresented communities. Dr. Renã A.S. Robinson, a professor of chemistry at Vanderbilt Univers...

10/07/2026

PTSD, Health-Related Social Needs Together Increase Cognitive Risks Significantly in Veterans - U.S. Medicine

10/07/2026

Both dogs and humans with dementia show similar brain patterns

For the first time, researchers have shown that dogs experiencing cognitive decline and humans with Alzheimer’s have similar brain patterns.

10/05/2026

Mouse study suggests new approach to preventing brain cell death from certain neurological diseases

In a mouse study, WashU Medicine researchers show that a drug injected into the body can reduce damage caused by a protein called tau, which accumulates in the brain in Alzheimer’s and related neurological diseases.

10/02/2026

You can now watch the video from this year's Norman R. Seay Academic Lecture. Renã AS Robinson, PhD speaks on "Measures to Achieve Equity in Alzheimer’s Disease Research."

The 2026 Norman R. Seay Lecture was held as part of a 2-part experi...

10/02/2026

Alzheimer’s risk gene APOE4 may have a reversible weakness

The Alzheimer’s risk gene APOE4 may actively damage brain blood vessels and sabotage the cellular systems that remove harmful proteins. Researchers were able to reverse some of these effects in experiments, revealing promising new targets for Alzheimer’s, Parkinson’s, and other neurodegenerati...